Abstract
Objectives
We investigated the relationship between lead in air (Pb‐A) measured by personal sampling and blood lead (Pb‐B) in workers with relatively low lead exposure to estimate the permissible air concentration of lead corresponding to the biological tolerance value of Pb‐B of 15 µg/dL.
Methods
We collected air samples at a lead‐acid battery factory in Japan by personal sampling devices attached to 32 workers (19 males and 13 females) and measured Pb‐A by a graphite furnace atomic absorption spectrophotometer in 2017‐2020. In addition, we collected information on age, smoking habits, Pb‐B, and urinary δ‐aminolevulinic acid from the records of medical examinations for lead poisoning. Samples were collected two times from four workers, resulting in 36 data sets.
Results
Before analyses, we excluded four inappropriate data sets. The levels of Pb‐A in the factory and Pb‐B in the workers were almost under the current permissible limits. Multiple regression models showed significant correlations between Pb‐B and Pb‐A, and sex, and borderline significance between Pb‐B and age. Based on them, we calculated Pb‐A corresponding to Pb‐B 15 μg/dL, and obtained similar values to the current occupational exposure limit (OEL) of 30 μg/m3, with slight variation between sex and age.
Conclusion
These results validate OEL, although supplementary conditions in terms of sex and age may be necessary.
Keywords: air lead, blood lead, multiple regression, δ‐aminolevulinic acid
1. INTRODUCTION
Lead is a major metal that has been used in various industrial fields since ancient times. In previous times, many workers engaged in lead refining, printing, and storage battery manufacturing, and inhaled lead‐containing dust leading to the effects of lead poisoning such as anemia, abdominal pain, and peripheral and central nerve disorder. In recent years in Japan, however, few workers are exposed to high levels of lead due to protective measures against lead exposure, such as protective masks and exhaust ventilation systems.
Blood lead (Pb‐B) levels are representative of the Biological Exposure Indices (BEI) for occupational lead exposure.1, 2 In Japan, the current biological tolerance value of Pb‐B is proposed by the Japan Society for Occupational Health as 15 μg/dL, which was amended in 2013 from 40 μg/dL that had been set in 1994.3, 4
The relationship between Pb‐B and lead in air (Pb‐A) has been studied since the 1970s to estimate the permissible air concentration of lead, but many of the studies involved workers with high exposure levels. King et al5 investigated workers at three lead factories and found that the slopes of the regression equations for Pb‐A and Pb‐B were 0.014‐0.068, and the intercept was 30 to 46 μg/dL. Garside et al6 similarly obtained the regression equation Y = 0.0514X + 38.54, but it was based on workers with Pb‐B of 30 μg/dL or higher. Bishop and Hill7 obtained similar results, but the exposure levels of lead in workers were also high, without data around 15 μg/dL, the biological tolerance value of Pb‐B in Japan.
In recent years, Karita et al8 investigated workers in copper smelting plants in Japan, whose lead exposure levels were relatively low. They obtained the regression equation Y (Pb‐B) = 10.34 logX (Pb‐A) − 0.64, and estimated 32 μg/m3 as the permissible air concentration of lead corresponding to the biological tolerance value of Pb‐B, 15 μg/dL. Based on the results, the occupational exposure limit (OEL) of lead was set at 30 μg/m3 by the Japan Society for Occupational Health in 2016.9 However, although the levels of Pb‐B were relatively low, ranging from 8.9 to 25.7 μg/dL, the range of Pb‐A in the workplace was marked, from 7 to 313 μg/m3, which were not obtained by personal sampling, but in the field. In short, these previous studies did not consider the biological tolerance value of Pb‐B in Japan, or their exposure assessment of Pb‐A was not precise because of the lack of personal sampling, leading to hesitation to apply them for the estimation of the permissible air concentration of lead in workers in Japan. Therefore, the purpose of this study was to estimate the permissible air concentration of lead corresponding to the biological tolerance value of Pb‐B of 15 µg/dL, based on multiple regression models obtained from Pb‐B of workers with relatively low lead exposure and Pb‐A measured by their personal sampling.
2. MATERIALS AND METHODS
2.1. Subjects
The target factory of the present study was a lead‐acid battery factory. The factory manufactured lead‐acid batteries for automobiles and industrial use, and lead oxide dust and fumes were generated in the factory. There were seven workplaces in the factory and categorized into five: battery assembly, laundry, battery case molding, battery inspection and packaging, and casting. During the period from September 2017 to March 2020, after obtaining informed consent, 32 workers (19 males and 13 females) engaged in their work while wearing a personal sampler near the mouth or nose for measuring Pb‐A. These personal samplings were performed within 1‐2 weeks before or after a medical examination for lead poisoning, and we used their Pb‐B and urinary δ‐aminolevulinic acid (ALA‐U) data for analysis. Pb‐B and ALA‐U levels in the workers were measured every 6 months as medical examinations for lead poisoning. We also collected information on age and smoking habits from the results of such medical examinations. One male and three female workers participated two times in the personal samplings, whose intervals were at least 6 months, resulting in 20 male data sets from 19 male workers and 16 female data sets from 13 female workers. Therefore, the total number of data sets was 36. The workers did not wear dust masks because the lead concentrations in the air of the workplaces were not so high that enough to require them.
2.2. Sampling and measurement of Pb‐A levels
A personal sampling device for Pb‐A measurement consisted of a mini pump (MP‐W5P type, SIBATA SCIENTIFIC TECHNOLOGY LTD., Saitama, Japan), a personal sample holder (PS‐33 type, SIBATA SCIENTIFIC TECHNOLOGY LTD., Saitama, Japan), and a fluorine‐resin‐treated glass fiber filter (TF98, φ25, SIBATA SCIENTIFIC TECHNOLOGY LTD., Saitama, Japan). The filter holder was attached to the collar of the worker, with a flow rate of 2.5 L/minute for about eight working hours. The sampling periods were 3‐10 consecutive days per person, set according to the numbers of days that covered all the work performed by the worker. Based on “Working Environment Measurement Guideline four Metals,”10 the collected samples were heated and dissolved in a solution diluted with 60% nitric acid, and then quantitatively analyzed using an ICP emission spectroscopic analyzer (iCAP7400 Duo, Thermo Fisher Scientific, Tokyo, Japan) at a wavelength of 220.353 nm. A linear calibration curve was prepared by the matrix matching method and concentrations of lead were quantified. From the measured values, the 8‐hour Time Weighted Average (TWA) of each day was calculated, and the geometric means (GMs) of the TWAs of all days were taken as the individual Pb‐A. The limit of quantification was 0.17 μg/m3 for Pb‐A.
2.3. Measurement of Pb‐B and ALA‐U levels
Pb‐B levels were measured using a graphite furnace atomic absorption spectrophotometer (ZA3700, ZA3000, Hitachi High‐Tech Science Corporation, Tokyo, Japan) with a wavelength of 283.3 nm. The analysis was performed using the methods of Subramanian et al11 with modifications. A peripheral blood sample was diluted with ultrapure water containing Triton X‐100 as a surfactant and diammonium hydrogen phosphate as an interference inhibitor for the analysis. A linear calibration curve was prepared by the matrix matching method and quantified.
ALA‐U levels were measured by HPLC (LaChrom Elite L‐2000 Series, Hitachi High‐Tech Corporation). The analysis was performed by modifying the methods of Okayama et al12 and Endo et al13 Reaction solution A (acetylacetone/ethanol/sodium chloride/ultrapure water) and reaction solution B (formaldehyde/ultrapure water) were added to urine and heated in boiling water to make ALA a fluorescent derivative for the analysis. In the liquid chromatograph, the mobile phase (methanol/acetic acid/ultrapure water) and ODS column (TSK‐gel ODS‐80Ts, 4.6 × 150 mm, 5‐μm particles, Tosoh) were separated, and the fluorescence detector (excitation wavelength 363 nm, measurement wavelength 463 nm) was used for detection. A linear calibration curve was prepared by the absolute calibration curve method and quantified. ALA‐U was corrected with a urine‐specific gravity of 1.020.
Pb‐B levels were measured at the Special Reference Laboratory Inc (SRL, Tokyo, Japan, which is a nationwide clinical laboratory). ALA‐U levels were measured at Keio University but were measured at SRL only in the fall of 2018. The limits of quantification were 1.0 μg/dL for Pb‐B and 0.1 mg/L for ALA‐U.
2.4. Statistical analysis
The means of age, Pb‐B, ALA‐U, and Pb‐A in the subgroups divided by sex or smoking habits were compared by Student’s t test. Smoking ratios in the subgroups divided by sex were compared by calculating the chi‐square value and phi coefficient by the chi‐square test. Pearson’s correlation coefficients between age, Pb‐B, ALA‐U, and Pb‐A were calculated and simple regression analyses of Pb‐A and Pb‐B were performed. Outliers were judged by the Smirnov‐Grubbs test. Multiple regression analyses were performed for data sets, using Pb‐B as a dependent variable and other factors, such as Pb‐A, age, sex, and smoking habit, as independent variables. Coefficients of determination (R 2s) of the multiple regression models were calculated to judge their fitness, whose significance was tested by analysis of variance (ANOVA). Variance inflation factors (VIFs) were confirmed for the diagnosis of multicollinearity. Statistical analyses were performed using IBM SPSS Statistics V25 (SPSS Japan) along with Excel 2016 for simple calculations. The significance level was set to <5% two‐tailed.
3. RESULTS
3.1. Subjects
Table 1 shows Pb‐A levels in total data sets and subgroups divided by workplaces. Data on the control Pb‐A were obtained from the same company’s non‐lead‐exposed office. In Laundry, Pb‐A in Plant B (mean 12.00 µg/m3) was higher than that in Plant A (mean 5.56 µg/m3), probably because more clothes were handled in Plant B than in Plant A. The assembly and casting workplaces, which were prone to lead dust and fumes, had relatively high Pb‐A levels (mean 6.79 µg/m3, 10.55 µg/m3). In addition, Pb‐A was relatively high in laundry workplaces where lead dust was indirectly brought in (mean 9.59 µg/m3). Lead was also detected in controls, although Pb‐A levels were very low (mean 0.68 µg/m3).
TABLE 1.
Pb‐A levels in total data sets and subgroups divided by workplaces
| Workplaces | n | % | Pb‐A (µg/m3) | |
|---|---|---|---|---|
| Mean ± SD | Range | |||
| Controls | 2 | 0.68 | 0.60‐0.76 | |
| Total | 36 | 100 | 6.65 ± 4.20 | 1.61‐17.74 |
| Assembly | 8 | 22.2 | 6.79 ± 3.23 | 3.34‐12.89 |
| Small batteries | 6 | 16.7 | 7.90 ± 2.96 | 4.82‐12.89 |
| Large batteries | 2 | 5.6 | 3.49 | 3.34‐3.64 |
| Laundry | 8 | 22.2 | 9.59 ± 4.35 | 3.40‐17.74 |
| Plant A | 3 | 8.3 | 5.56 | 3.40‐7.14 |
| Plant B | 5 | 13.9 | 12.00 ± 3.42 | 9.25‐17.74 |
| Battery case molding | 5 | 13.9 | 3.17 ± 1.25 | 1.61‐4.27 |
| Battery inspection and packaging | 13 | 36.1 | 5.48 ± 4.21 | 1.67‐14.42 |
| Casting | 2 | 5.6 | 10.55 | 7.83‐13.26 |
Assembly was a workplace where lead‐acid battery plates were handled. Laundry was a workplace where workers’ clothes were washed. In addition to washing clothes in Plant A, workers in Plant B were engaged in room cleaning in other non‐lead‐exposed offices. Battery case molding was a workplace where battery cases were molded. Battery inspection and packaging was a workplace where batteries were inspected and packed before shipping. Casting was a workplace for casting lead‐acid battery substrates.
Abbreviations: n, number of data sets; Pb‐A, lead in the air.
From the 36 data sets, we excluded four from subsequent analyses: a data set from one male included an extraordinarily high ALA‐U, which suggested that he had been in an abnormal condition derived from unknown factors other than lead, and three data sets were from females in their 50s, who must have been in postmenopause, which may cause elevated Pb‐B levels due to the intrinsic release of lead from bone stores14, 15, 16, 17 (Table S1).
Table 2 shows the characteristics of the study data sets of workers, divided by sex and smoking habits. There were no significant differences in age, Pb‐B, or Pb‐A between sex or smoking habits, while ALA‐U was significantly higher in smokers than non‐smokers. The means of Pb‐B in the total and subgroups were all lower than the biological tolerance value (15 μg/dL), but there were three data sets over it. However, all ALA‐U data were lower than the biologically acceptable value of ALA‐U, 5 mg/L.3 All Pb‐A data were also lower than OEL of lead, 30 μg/m3.
TABLE 2.
Characteristics of study data sets
| Group | n | % | Age (years) | Pb‐B (µg/dL) | ALA‐U (mg/L) | Pb‐A (µg/m3) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Range | Mean ± SD | Range | Mean ± SD | Range | Mean ± SD | Range | |||
| Total | 32 | 100 | 39.6 ± 14.0 | 21‐73 | 10.2 ± 4.0 | 3.1‐18.0 | 1.10 ± 0.29 | 0.53‐1.78 | 6.88 ± 4.26 | 1.61‐17.74 |
| Sex | ||||||||||
| Males | 19 | 59.4 | 36.1 ± 13.3 | 21‐60 | 11.1 ± 4.4 | 3.1‐18.0 | 1.09 ± 0.28 | 0.60‐1.78 | 5.65 ± 3.69 | 1.61‐13.26 |
| Females | 13 | 40.6 | 44.9 ± 13.8 | 24‐73 | 8.9 ± 2.9 | 4.6‐13.9 | 1.10 ± 0.32 | 0.53‐1.58 | 8.68 ± 4.53 | 2.97‐17.74 |
| Smoking habits | ||||||||||
| Smokers | 15 | 46.9 | 37.4 ± 10.6 | 24‐60 | 11.1 ± 4.3 | 3.1‐18.0 | 1.28 ± 0.25* | 0.96‐1.78 | 6.29 ± 5.11 | 1.61‐17.74 |
| Non‐smokers | 17 | 53.1 | 41.6 ± 16.5 | 21‐73 | 9.4 ± 3.6 | 4.6‐15.4 | 0.93 ± 0.21 | 0.53‐1.36 | 7.40 ± 3.43 | 2.17‐13.26 |
Sex was classified into males and females, smoking habits were classified into smokers and non‐smokers, and compared by Student’s t test.
Abbreviations: ALA‐U, δ‐aminolevulinic acid in urine; n, number of data sets; Pb‐A, lead in the air; Pb‐B, lead in blood.
P < .05 (unpaired Student’s t test).
Table 3 shows the age‐classified numbers of smokers and Pb‐B levels divided by sex. The smoking rate in males was higher than in females, but the difference was not significant (χ2 = 0.622, P = .430, φ = 0.139). Although statistical analysis was impossible due to the small numbers, there was no obvious relationship between age and Pb‐B, or age‐classified smoking rates and Pb‐B in either male or female data sets.
TABLE 3.
Age‐classified number of smokers and blood lead levels (µg/dL)
| Age groups | Males | Females | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | Smokers | % | Mean ± SD | Range | n | % | Smokers | % | Mean ± SD | Range | |
| Total | 19 | 100 | 10 | 52.6 | 11.1 ± 4.4 | 3.1‐18.0 | 13 | 100 | 5 | 38.5 | 8.9 ± 2.9 | 4.6‐13.9 |
| 20‐29 | 7 | 36.8 | 2 | 28.6 | 9.3 ± 5.3 | 3.4‐18.0 | 2 | 15.4 | 1 | 50.0 | 6.5 | 4.6‐8.4 |
| 30‐39 | 6 | 31.6 | 5 | 83.3 | 11.4 ± 1.9 | 9.5‐13.9 | 4 | 30.8 | 1 | 25.0 | 10.7 ± 3.3 | 7.7‐13.9 |
| 40‐49 | 2 | 10.5 | 2 | 100.0 | 10.5 | 3.1‐17.8 | 4 | 30.8 | 3 | 75.0 | 8.7 ± 2.8 | 4.9‐11.3 |
| ≥50 | 4 | 21.1 | 1 | 25.0 | 14.0 ± 1.1 | 13.0‐15.4 | 3 | 23.1 | 0 | 0.0 | 8.5 | 5.8‐10.3 |
3.2. Relationships among age, Pb‐B, ALA‐U, and Pb‐A
Next, we examined the relationship between Pb‐A and Pb‐B in the workers. Figure 1 shows scatter diagrams and regression lines between Pb‐A and Pb‐B in the total and sex‐divided data sets. While the data were scattered widely in the scatter diagram in the total data sets, dividing them by sex led to distributions in a relatively high range of Pb‐B in males and in a low range of Pb‐B in females. However, the primary regression equations in total, males, and females were not significant. Actually, the matrix of correlation coefficients shows that those between Pb‐A and Pb‐B in males and females were higher than that in the total data sets, although not significant (Table 4). Only the correlation coefficient between age and Pb‐A in females was significant, and that between age and Pb‐B in males was relatively high, although not significant. The correlation coefficients between Pb‐B and ALA‐U were relatively low.
FIGURE 1.

Scatter diagrams and regression lines between Pb‐A and Pb‐B. Each dot shows one case
TABLE 4.
Correlation matrix for age, Pb‐B, ALA‐U, and Pb‐A
| Pearson’s correlation coefficient | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total (n = 32) | Males (n = 19) | Females (n = 13) | ||||||||||
| Age | Pb‐B | ALA‐U | Pb‐A | Age | Pb‐B | ALA‐U | Pb‐A | Age | Pb‐B | ALA‐U | Pb‐A | |
| Age (years) | 1 | 1 | 1 | |||||||||
| Pb‐B (μg/dL) | 0.127 | 1 | 0.349 | 1 | −0.008 | 1 | ||||||
| ALA‐U (mg/L) | −0.121 | 0.159 | 1 | −0.202 | 0.130 | 1 | −0.050 | 0.271 | 1 | |||
| Pb‐A (µg/m3) | −0.092 | 0.167 | 0.000 | 1 | 0.055 | 0.320 | −0.186 | 1 | −0.564* | 0.281 | 0.183 | 1 |
Abbreviations: ALA‐U, δ‐aminolevulinic acid in urine; Pb‐A, lead in the air; Pb‐B, lead in blood.
P < .05 (two‐tailed).
3.3. Linear multiple regression models predicting Pb‐B
Based on the results above, linear multiple regression analyses were performed to investigate the relationship between Pb‐B as a dependent variable and Pb‐A with other factors as independent variables. Table 5 shows a summary of multiple regression models predicting Pb‐B in total data sets. In model 1, Pb‐A, age, sex, and smoking habits including a constant term were used as independent variables. Among them, Pb‐A and sex showed significant correlations with Pb‐B, and age showed a borderline significance. All VIFs were <10.0, meaning no problem with multicollinearity, and R 2 of the model was significant, indicating its utility to predict Pb‐B. Model 2, where smoking habits were omitted from the independent variables because of their low β, also showed significant correlations of Pb‐B with Pb‐A and sex. All VIFs were <10.0, meaning no problem with multicollinearity, and R 2 of the model was significant, also indicating its predictability for Pb‐B.
TABLE 5.
Summary of multiple regression analysis for variables predicting lead in blood in total data sets (n = 32)
| Variables | Model 1 | Model 2 | ||||||
|---|---|---|---|---|---|---|---|---|
| B | SE | β | P | B | SE | β | P | |
| Constant | 0.231 | 3.211 | .943 | 1.787 | 3.140 | .574 | ||
| Pb‐A (µg/m3) | 0.382 | 0.166 | 0.410 | <.05 | 0.351 | 0.169 | 0.376 | <.05 |
| Age (years) | 0.102 | 0.050 | 0.359 | .050 | 0.091 | 0.051 | 0.321 | .083 |
| Sex (male/female) | 3.933 | 1.474 | 0.494 | <.05 | 4.030 | 1.513 | 0.506 | <.05 |
| Smoking habits | 2.046 | 1.288 | 0.261 | .124 | ||||
| R2 (Adjusted R 2) | 0.306 (0.203)* | 0.241 (0.159)* | ||||||
Sex involved dummy variables with 1 for males and 0 for females. Smoking habits were dummy variables with 1 for smokers and 0 for non‐smokers.
Abbreviations: n, number of data sets; Pb‐A, lead in the air;SE, standard error.
P < .05 (two‐tailed).
4. DISCUSSION
In the present study, we investigated the relationship of Pb‐B and Pb‐A in workers with relatively low lead exposure in a lead‐acid battery factory in Japan, using data on Pb‐A measured by a personal sampler. By performing multiple regression analysis, we obtained multiple regression models to predict Pb‐B from Pb‐A along with age, sex, and smoking habits.
The average Pb‐A level in the total data sets of workers was 6.65 µg/m3, ranging from 1.61 to 17.74 µg/m3, which were all above Pb‐A in the control workplaces (0.68 µg/m3) and all below OEL of 30 µg/m3 for lead in the air.9 The average Pb‐B based on them was 10.2 µg/dL, ranging from 3.1 to 18.0 µg/dL, which were all over the previously reported GM of Pb‐B 2.2 μg/dL in workers before engaging in work involving exposure to lead18 and below the biological tolerance value of Pb‐B (15 μg/dL), except for three data sets. These results indicate that the targeted subjects were suitable for the purpose of this study, to aim at workers with low lead exposure. Indeed, the targeted lead workplaces were not designated as the area necessary for protective measures against lead exposure based on the results of measurement of airborne lead concentrations, and the observed low Pb‐A levels assured the occupational safety. Therefore, the workers were not required to wear dust masks, which enabled us to observe the unhindered relationship between Pb‐A and Pb‐B in them. However, there were three data sets of workers whose Pb‐B levels were above the biological tolerance value, although the levels were only slightly excessive. We do not know the reason for this, but they were all male and two had smoking habits, and levels may be affected by other factors such as lead‐contaminated food or fluctuation of lead exposure in the workplace.
In previous studies, primary linear regression equations between Pb‐B and Pb‐A were derived in lead‐exposed workers, and several values of Pb‐A corresponding to the biological tolerance value of Pb‐B were proposed (Table S2). In most cases, the investigated workers were exposed to high levels of lead, which allowed the drawing of suitable linear regression lines because of the wide ranges of Pb‐B and Pb‐A. In this study, however, the lead exposure levels were relatively low, making it difficult to identify a significant correlation between Pb‐B and Pb‐A (the correlation coefficient was 0.167; the regression equation was Y = 0.156X + 9.135, P = .361). Therefore, we performed multiple regression analyses, including possible confounding factors as independent variables, such as age, sex, and smoking habits, which were obtained from the results of medical examinations for lead poisoning.
We excluded four data sets from the total of 36 to construct multiple regression models. The value of ALA‐U in the excluded male data set was extremely high in consideration of its Pb‐B level, and statistically judged as an outlier by the Smirnov‐Grubbs test as well (Table S1). In general, ALA‐U levels are affected by various factors other than lead, such as acute intermittent porphyria (AIP) that increases ALA‐U,19 and barbiturates can affect ALA‐U.20 We do not know the reason for the high ALA‐U (4.84 mg/L), but it may be beneficial to exclude outliers that can alter the relationship between Pb‐A and Pb‐B. In addition, we excluded three data sets from females in their 50 seconds, two of whom showed Pb‐B above the biological tolerance value. In general, the Pb‐B levels of postmenopausal women may increase since the decrease in estrogen secretion induces enhanced bone metabolism, leading to the release of lead that is accumulated in bones to peripheral blood.17 Therefore, it may be reasonable to exclude postmenopausal women to observe the relationship between external exposure to lead and Pb‐B.
The multiple regression models obtained indicate that Pb‐B could be explained by Pb‐A in low‐level lead‐exposed workers, and would be affected by sex, and probably by age as well, but not by smoking habits. In other words, the level of Pb‐B in males was higher than that in females, and the Pb‐B level may increase with aging, while smoking was not relevant to Pb‐B. Bone lead levels increase with age in both males and females, and adult males have higher lead levels in bones than females.21 In addition, more lead is concentrated in the blood of males, because males have higher blood hematocrit levels than females, and the lead binds to red blood cells. The potential effects of sex and age on Pb‐B can be explained by the above. It is widely believed that smokers have higher Pb‐B than non‐smokers because tobacco contains lead,22, 23 which is inconsistent with the results of this study. It may be necessary to reconsider the close relationship between smoking habits and Pb‐B, which may be just an incidental observation derived from some confounding factors.
Since smoking habit was not a significant variable, we used model 2 to calculate Pb‐A corresponding to Pb‐B 15 μg/dL by substituting sex and age. The following multiple regression equation was obtained. Workers' predicted Pb‐B is equal to 1.787 + 0.351 × (Pb‐A) + 0.091 × (age) + 4.030 × (sex), where Pb‐A is measured in μg/m3, age is measured in years, and sex is coded as 0 = female, 1 = male. Regarding the age, four patterns of 20, 40, and 60 years, and mean age were substituted, and the results are shown in Table S3. The calculated values of Pb‐A at the mean ages were 16.8 µg/m3 and 26.0 µg/m3 in males and females, respectively, although they showed an age‐dependent decrease, ranging from 10.6 µg/m3 in males of 60 years to 32.5 µg/m3 in females of 20 years.
When the current OEL in Japan was set at 30.0 μg/m3, the research results of Ibiebele24 and Karita et al8 revealed that Pb‐A levels corresponding to Pb‐B 15 μg/dL were 22‐25 and 32 μg/m3, respectively (Table S2). The results of our study were similar to these previous ones despite the different methods of Pb‐A measurement: using personal samplers in the former and field measurements in the latter. Because more reliable data on Pb‐A can be obtained by personal sampling than the measurement in the field, the current OEL in Japan, 30.0 μg/m3, has been further validated by the results of our study. However, it may be necessary to add supplementary conditions in terms of sex and age.
This study has some limitations. The data size of this study was relatively small compared with those of previous ones (Table S2). However, it was difficult to obtain data on Pb‐A from workers by personal samplers, which are much more accurate and valuable than those by field measurements. We excluded data on female workers in their 50s, leaving the necessity of additional consideration of postmenopausal women. We calculated Pb‐A corresponding to the current biological tolerance value of Pb‐B 15 μg/dL, which is not an established value; for example, that level of Pb‐B may show reproductive toxicity.25 In the future, it will be necessary to review the biological tolerance value of Pb‐B as well as OEL corresponding to it.
5. CONCLUSIONS
We demonstrated that Pb‐B of workers working in a lead‐acid battery factory in Japan could be predicted from Pb‐A, which was measured using personal samplers, by multiple regression models including sex and age as independent variables. Based on the models, we calculated Pb‐A corresponding to Pb‐B 15 μg/dL, and obtained values similar to the current OEL of 30 μg/m3, with slight variation between sex and age. These results validate OEL, although supplementary conditions in terms of sex and age may be necessary.
AUTHOR CONTRIBUTIONS
AO conceived the study, collected and analyzed the data, and wrote the manuscript. HH reviewed and edited the manuscript. All authors have read and approved the final version of the manuscript.
DISCLOSURE
Approval of the research protocol: This study was conducted according to the principles expressed in the Declaration of Helsinki and was approved by the Kitasato University Medical Ethics Organization (No. B17‐108). Informed consent: Informed written consent was obtained from each participant before starting the study. Registry and the registration no. of the study/trial: N/A. Animal studies: N/A. Conflicts of interest: AO is an employee of The Furukawa Battery Co., Ltd. No other author has reported a potential conflict of interest relevant to this article.
Supporting information
Table S1
Table S2
Table S3
ACKNOWLEDGMENTS
The authors are grateful to Honorary Professor Kazuyuki Omae of Keio University for discussing the statistical analysis of this study, Yoko Eitaki of Keio University who provided the measurement information of Pb‐B and ALA‐U, and Naoshi Fukushima, Shuji Kataoka, Ayaka Tone, Kaito Iijima, Ritsuko Takano, and Mayumi Saito, of Furukawa Battery Co., Ltd. for collecting data.
Ono A, Horiguchi H. Relationship between personal‐sampled air lead and blood lead in low‐lead‐exposure workers in Japan to apply multiple regression models determining permissible air lead concentration. J Occup Health. 2021;63:e12264. 10.1002/1348-9585.12264
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- 1.Alessio L, Foa V. Lead. In: Alessio L, Berlin A, Roi R, Boni M, eds. Human Biological Monitoring of Industrial Series. Vol. 1. CEC Joint Research Centre Ispra Establishment; 1983:105‐132. [Google Scholar]
- 2.World Health Organization . Chapter 3.3 Inorganic Lead. In: Biological Monitoring of Chemical Exposure in the Workplace. Vol. 1. Geneva: World Health Organization; 1996. [Google Scholar]
- 3.Japan Association of Industrial Health . Lead and compounds (as Pb except alkyl lead compounds) [CAS No.7439‐92‐1] OEL‐B 40 µg/100ml. J Ind Health. 1994;36:278‐282 [Translated from Japanese]. [Google Scholar]
- 4.Japan Society for Occupational Health . Lead and compounds (as Pb except alkyl lead compounds) [CAS No.7439‐92‐1] OEL‐B 15 µg/100ml. J Occup Health. 2013;55:214‐221 [Translated from Japanese]. [Google Scholar]
- 5.King E, Conchie A, Hiett D, Milligan B. Industrial lead absorption. Ann Occup Hyg. 1979;22(3):213‐239. [DOI] [PubMed] [Google Scholar]
- 6.Garside PS, Buncher CR, Lerner S. Relationship of air lead and blood lead for workers at an automobile battery factory. Int Arch Occup Environ Health. 1982;50(1):1‐10. [DOI] [PubMed] [Google Scholar]
- 7.Bishop L, Hill WJ. A study of the relationship between blood levels and occupational air lead levels. Am Stat. 1983;37(4):471‐475. [Google Scholar]
- 8.Karita K, Shinozaki T, Yano E, Amari N. Blood lead levels in copper smelter workers in japan. Ind Health. 2000;38(1):57‐61. [DOI] [PubMed] [Google Scholar]
- 9.Japan Society for Occupational Health . Lead and compounds (as Pb except alkyl lead compounds) [CAS No.7439‐92‐1] OEL‐M 0.03mg/m3 . J Occup Health. 2016;58:222‐228 [Translated from Japanese]. [Google Scholar]
- 10.Japan Association for Working Environment Measurement . Working Environment Measurement Guidebook four [Metals]. Japan Association for Working Environment Measurement; 2017:154‐184 [Translated from Japanese]. [Google Scholar]
- 11.Subramanian KS, Meranger JC. A rapid electrothermal atomic absorption spectrophotometric method for cadmium and lead in human whole blood. Clin Chem. 1981;27(11):1866‐1871. [PubMed] [Google Scholar]
- 12.Okayama A, Fujii S, Miura R. Optimized fluorometric determination of urinary delta‐aminolevulinic acid by using pre‐column derivatization, and identification of the derivative. Clin Chem. 1990;36(8 Pt 1):1494‐1497. [PubMed] [Google Scholar]
- 13.Endo Y, Okayama A, Endo G, Ueda T, Nakazono N, Horiguchi S. Improvement of urinary delta‐aminolevulinic acid determination by HPLC and fluorescence detection using condensing reaction with acetylacetone and formaldehyde. Sangyo Igaku. 1994;36(2):49‐56. [DOI] [PubMed] [Google Scholar]
- 14.Symanski E, Hertz‐Picciotto I. Blood lead levels in relation to menopause, smoking, and pregnancy history. Am J Epidemiol. 1995;141(11):1047‐1058. [DOI] [PubMed] [Google Scholar]
- 15.Garrido Latorre F, Hernández‐Avila M, Tamayo Orozco J, et al. Relationship of blood and bone lead to menopause and bone mineral density among middle‐age women in Mexico City. Environ Health Perspect. 2003;111(4):631‐636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jackson LW, Cromer BA, Panneerselvamm A. Association between bone turnover, micronutrient intake, and blood lead levels in pre‐ and postmenopausal women, NHANES 1999–2002. Environ Health Perspect. 2010;118(11):1590‐1596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Manocha A, Srivastava LM, Bhargava S. Lead as a risk factor for osteoporosis in post‐menopausal women. Indian J Clin Biochem. 2017;32(3):261‐265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ono A, Horiguchi H. Reassessment of the threshold of the blood lead level to increase urinary delta‐aminolevulinic acid based on their relationship in recent lead workers in Japan. J Occup Health. 2021;63(1):e12202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Inafuku K, Takamiyagi A, Oshiro M, Kinjo T, Nakashima Y, Nonaka S. Alteration of mRNA levels of delta‐aminolevulinic acid synthase, ferrochelatase and heme oxygenase‐1 in griseofulvin induced protoporphyria mice. J Dermatol Sci. 1999;19(3):189‐198. [DOI] [PubMed] [Google Scholar]
- 20.Japan Society of Anesthesiologists . Guidelines for the Use of Anesthetics and Anesthesia‐Related Drugs. 3rd ed. Tokyo: Barbiturates. 2015:93‐95 [Translated from Japanese]. [Google Scholar]
- 21.Barry PS. A comparison of concentrations of lead in human tissues. Br J Ind Med. 1975;32(2):119‐139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lazarević K, Nikolić D, Stosić L, Milutinović S, Videnović J, Bogdanović D. Determination of lead and arsenic in tobacco and cigarettes: an important issue of public health. Cent Eur J Public Health. 2012;20(1):62‐66. [DOI] [PubMed] [Google Scholar]
- 23.Pinto E, Cruz M, Ramos P, Santos A, Almeida A. Metals transfer from tobacco to cigarette smoke: evidences in smokers’ lung tissue. J Hazard Mater. 2017;325:31‐35. [DOI] [PubMed] [Google Scholar]
- 24.Ibiebele DD. Air and blood lead levels in a battery factory. Sci Total Environ. 1994;152(3):269‐273. [DOI] [PubMed] [Google Scholar]
- 25.National Toxicology Program . NTP Monograph on Health Effects of Low‐Level Lead. Washington, D.C.: Office of Health Assessment and Translation, National Institutes of Health. U.S. Department of Health and Human Services; 2012. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Table S1
Table S2
Table S3
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
